Loading provider…
Loading provider…
Orthopaedic Surgery Physician in Galveston, TX
NPI: 1447662630Primary Practice Location
UNIVERSITY OF TEXAS MEDICAL BRANCH GALVESTON
301 8th St, Galveston, TX
Primary Employer
Utmb Faculty Group Practice
utmb.edu
HQ Phone
Get M.D. Jie's Phone Numberphone_androidMobile
Get M.D. Jie's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
2021 - 2026

American Board of Orthopaedic Surgery
Orthopaedic Surgery
University of North Carolina School of Medicine
med.unc.edu
Medical School
Until 2014
Duke University Hospital
Fellowship • Foot and Ankle Orthopaedics
2019 - 2020
University of Texas Medical Branch Hospitals
Residency • Orthopaedic Surgery
2014 - 2019
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 59 | 73 |
| 2 | 99203New patient outpatient visit, total time 30-44 minutes | 49 | 49 |
| 3 | 99204New patient office or other outpatient visit, 45-59 minutes | 21 | 21 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 12 | 14 |
| 5 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 11 | 11 |
The Lisfranc Injury: A Literature Review of Anatomy, Etiology, Evaluation, and Management:
Authors: Selene Parekh, Rishin Kadakia, Craig Akoh
Journal: Foot Ankle Int
Publication Date: 2020-06-24
Base of Fifth Metatarsal Fractures: A Meta-analysis of Plate Fixation.
Authors: Cory Janney, Keenan Horani, Vinod Panchbhavi
Journal: Indian J Orthop
Publication Date: 2025-04-10
Lead Sponsor: United Therapeutics
Intervention / Treatment: DRUG: UT-15C (treprostinil diolamine)
Lead Sponsor: United Therapeutics
Intervention / Treatment: DRUG: Placebo, DRUG: Treprostinil Diolamine